| ALDH-1 | Aldehyde dehydrogenase-1 |
| CA 19-9 | Carbohydrate antigen 19-9 |
| CSCs | Cancer stem cells |
| CXCR4 00 | CX-C chemokine receptor type 4 |
| DMEM | Dulbecco’s Modified Eagle’s Medium |
| EMT | Epithelial–mesenchymal transition |
| FBS | Fetal bovine serum |
| FoxM1 | Forkhead box protein M1 |
| HPDE | Human pancreatic ductal epithelial cell line |
| IDT | Integrated DNA Technologies |
| IPMN | Intraductal papillary mucinous neoplasm |
| KOs | Knockouts |
| MAPK | Mitogen-activated protein kinase |
| MDSCs | Myeloid-derived suppressor cells |
| miRs | microRNAs |
| mTOR | Mammalian target of rapamycin |
| nMDSCs | Neutrophil-like heterogeneous myeloid-derived suppressor cells |
| NF-κB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| oncomiR | Oncogenic miR |
| PanIN | Pancreatic intraepithelial neoplasia |
| PCa | Pancreatic cancer |
| PCSCs | Pancreatic cancer stem cells |
| PDAC | Pancreatic ductal adenocarcinoma |
| PDCD4 | Programmed cell death 4 |
| PDGF | Platelet-derived growth factor |
| PI3K | Phosphoinositide-3-kinase |
| PNI | Perineural invasion |
| RPII | RNA polymerase 2 |
| SD | Standard Deviation |
| SHH | Sonic Hedgehog |
| TNM | Tumor-Node-Metastasis |
| UTRs | Untranslated regions |
| VEGF | Vascular endothelial growth factor |
| ZEB1 | Zinc Finger E-box binding homeobox 1 |